Fermion
Manufacturing · Finland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Lääketehtaantie 2, Oulu, Northern Ostrob...Phone Number
+358 94521764Website
www.fermion.fiRevenue
$54.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Fermion
Fermion's product portfolio consists of over 30 generic APIs and over 10 NCEs. Fermion is a fully owned subsidiary of Orion Corporation and headquartered in Espoo, Finland. Together with Orion Fermion is a fully integrated contract development and manufacturing organization (CDMO) and offer services covering both drug substances and drug products. Fermion's two state-of-the-art manufacturing sites as well as R&D facilities including a modern bench scale operation are all located in Finland. Fermion has systematically invested and expanded capabilities in the production of highly potent compounds (HPAPIs). Fermion operates according to current Good Manufacturing Practice (cGMP) and apply high environmental, health and safety and other sustainability standards. Fermion's facilities are regularly inspected by all the relevant authorities, including the U.S. Food and Drug Administration (FDA), and are frequently audited by Fermion's partners and customers. Fermion's valuesExplore more
Fermion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fermion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Fermion has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Fermion is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Fermion
Funding: Get notified immidiatlly once Fermion has new funding data
Product Launch: Get notified when Fermion launches new products
Fermion, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Fermion had a recent Job posting/layoffs
Earning: See what the market has to say on Fermion recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Fermion is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Fermion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fermion.
Fermion Tech Stack
A closer look at the technologies used by Fermion
Most Recent Scoops
Event
Product Marketing, Events, Sales, Compliance, Logistics / Supply Chain, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Event
Events
Event
Fermion News & Media
Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China's First SSTR4 Agonist Targeting Pain
GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4. FZ002-037 is a highly selective oral...Fermion's TYK2 JH2 Inhibitor FZ007-119 Granted IND Approval by China NMPA
GUANGZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain management, is pleased to announce the approval of the Investigational...Fermion's TYK2 JH2 Inhibitor FZ007-119 Granted IND Approval by China NMPA
GUANGZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain management, is pleased to announce the approval of the Investigational...Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA
GUANGZHOU, China, Jan. 10, 2024 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has announced today that China National Medical Products Administration...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fermion
Sign Up For FreeTo access detailed company insights
Fermion's product portfolio consists of over 30 generic APIs and over 10 NCEs. Fermion is a fully owned subsidiary of Orion Corporation and headquartered in Espoo, Finland. Together with Orion Fermion is a fully integrated contract development and manufacturing organization (CDMO) and offer services covering both drug substances and drug products.... Read More
